Scroll To Top
Search by Speciality

International Cancer Imaging Society (ICIS) Meeting and 17th Annual Teaching Course

Langenbeck-Virchow-Haus * | Berlin , GERMANY
From 450 to 550 USD
Event Preview
8
Days Left
For the
Event
Title: International Cancer Imaging Society (ICIS) Meeting and 17th Annual Teaching Course
Specialty: Radiology
Dates: From Oct, 2, 2017 to Oct, 4, 2017
Location: Berlin , GERMANY
Type: Course
Registration Cost: From 450 to 550 USD
Event Tools
  • Add to Favorites
  • Notify me by email
  • Claim this event
Add to my Calendar
  • Scientific Programm
  • Online registration
  • Exhibition floorplans
  • Sponsorship &
    Exhibition consensus
  • Virtual Booths
Oct
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for BERLIN , Germany.
General Info
Event Venue:

Langenbeck-Virchow-Haus *

BERLIN , GERMANY Visit the Venue to read more
Currency:
USD
Accreditation:

-

German delegates will receive 15 category B points in total for the three-day course. 

Monday 6 category B points, Tuesday 6 category B points, Wednesday 3 category B points.

Delegates attending a live case workshop will receive 3 category C points.


American delegates can have their EACCME European CME Credits converted to AMA PRA Category 1 Credit™ by applying to the AMA.


Download the 1 page form here:-


https://www.ama-assn.org/sites/default/files/media-browser/public/cme/eaccme-application-exp-2017.pdf


Send the completed  form to the AMA together with the EACCME certificate* and the non-refundable processing fee (AMA members $30 and non AMA members $75).  AMA certificates will be emailed within 3 business weeks. 


* The EACCME certificate will be automatically emailed to you once you have completed the ICIS course daily electronic surveys.


Please visit this link for further information https://www.ama-assn.org/education/uemseaccme-cme-credit-recognition


You will be able to generate your own certificate of attendance once you have completed our daily online feedback form.

Concerned Audience:
  • Medical_Professionals
  • Medical_students
  • Nurses
Event Overview
Welcome message:

The 17th annual course of our Society will focus on practically orientated education of cancer imaging through interactive teaching and the fostering of active learning. State of the art and novel quantitative and functional imaging techniques will be highlighted.


The Society aims to bring together radiologists, nuclear medicine physicians and other specialists with an interest in oncological imaging for the exchange of ideas and to organise scientific meetings, multicentre research studies, and postgraduate courses within the field.


Keynote lectures highlight the challenges of precision medicine and the role of imaging in patients undergoing immunotherapy.


Individual learning is emphasised by small group sessions, interactive workshops and computer based hands-on workshops fostering active participation.


A unique feature this year are the live-case workshops in interventional oncology. Delegates will view oncologic interventional therapies such as transarterial chemoembolization (TACE), radioembolization (SIRT), percutaneous microwave ablation (MWA) and radiofrequency ablation (RFA) in small groups in Berlin hospitals on Wednesday 4th October. Transport from the conference venue will be provided. Early registration is highly recommended due to the limited number of places


A session entitled cases we would like to read again will present interesting oncologic cases reviewed with the benefit of hindsight.


There will be scientific sessions, dedicated to proffered papers, presenting research in the field of imaging in oncology. There will also be a poster exhibition and the best overall paper and poster will be awarded a prize.

This course is designed for all radiologists, radiation oncologists, medical oncologists and other specialists interested in the diagnosis and management of cancer patients. 


The meeting will be held in the Langenbeck-Virchow Haus, Berlin Germany.


Berlin is one of Europe’s most vibrant capital cities, steeped in history and easily explored on foot or excellent public transport. It’s the perfect destination to spend a few days exploring in early autumn. From the Reichstag to the majestic Brandenburg gate, with myriad museums and a thriving art scene, as well as world class restaurants.


There will be a welcome drinks reception on Monday 2nd October, free to attend for all those who attend the first day of our meeting.


The course party will be held on Tuesday 3rd  October on the barge “Alexander von Humboldt”  taking us along many of the beautiful sights of Berlin during a delicious buffet dinner.


Learning objectives:


To improve your knowledge of:

- Cancer staging

- Response assessment

- Side effects / complications of oncologic therapies

- Interventional radiology in oncologic patients

- Structured reporting

- Imaging protocols in cancer imaging

- Differential diagnosis of focal lesions

Registration Needs updating Register Now
Currency:

USD

Registration Cost
Type
Early Registration

2017-08-24
Late Registration From: 2017-08-25 To: 0--
On site Registration
Registration
450
550
0

Group Registrations:

Group registrations not allowed

Accompanying Persons:

Accompanying persons not allowed

Registration Documents:
Letter of invitation:
We don’t provide letter of invitation
Letter of confirmation:
We don’t provide Letter of Confirmation
Proof of professional / educational status:
We don’t need Proof of professional/educational status
Online Abstract Submission:

We don’t accept Online Abstracts

Accommodation
Accommodation:

Langenbeck-Virchow-Haus

Luisenstraße 58

Berlin, Berlin, Germany

Scientific Content Up to Date
Submission Info

Abstracts that do not adhere to the following important points will be rejected:


The title should not exceed 15 words.  

The abstract should not exceed 250 words.

Please use authors’ initials and surnames only.

Qualifications should be omitted.  Do not include references, tables or figures.

Please do not use block capitals.


Please find examples at the bottom of the page.


Guidelines


You may choose among three different abstract types:

> Oral Scientific Presentation

> Poster Scientific Presentation

> Poster Educational Presentation


Oral Scientific Presentation

The abstract should be separated into “Aim”, “Methods”, “Results” and “Conclusion”. The abstract limit is 250 words.  Abstracts should not include promissory notes such as “We will provide additional data during our presentation.”  Authors of accepted oral presentations will be invited for a presentation within the Scientific Paper Sessions.  Presentation time will be 8 minutes with 2 minutes for Q&A (depending on the final program). 


Poster Scientific Presentation

The abstract should be separated into “Aim”, “Methods”, “Results” and “Conclusion”. The abstract limit is 250 words. 


Poster Educational Presentation

The abstract should be separated into “Learning Objectives”, “Content Organisation”,  and  “Conclusion”. The abstract limit is 250 words. 


Abstracts selected for presentation will be published in the Proceedings of the 17th International Cancer Imaging, given to all delegates and faculty. A downloadable version of your submission will be made available to our membership on the members only area of our website, and be available on the Cancer Imaging open access website. Authors of selected abstracts will be notified after Friday 30th June 2017.


It will be obligatory for all scientific presenters to be members of ICIS at the time of presentation in Glasgow. The annual membership fee of €95 will be added to the scientific presenters’ fee at registration if current membership is not in place. Membership will run for one year from date of registration; all standard member benefits will apply.


Queries may be addressed to the ICIS Secretariat

Tel: +44 (0)20 7036 8805 or Email: admin@cancerimagingsociety.org.uk


Submission deadline: Monday 29th May 2017


Examples


EXAMPLE - POSTER EDUCATIONAL


Chemotherapy Induced Cardiomyopathy: An Overview, Imaging Features, and Future Prospective


Authors: Divito D., Bondin M., Kirschner S. K., Stojanovska J., Ibrahim E., Frank L.


Learning objectives:


To review the spectrum of imaging findings of chemotherapy- induced cardiomyopathy in correlation with most common cytotoxic drugs and regimens. 


Content organisation:


Cardio toxic effect of chemotherapy is a well-recognized problem in cancer patients.  Cardio toxicity depends on multiple predisposing factors, specific components of the chemotherapy regimen, length of treatment, and dosage.


We will present the spectrum of most common cardiotoxic chemotherapy agents and their combinations, specific effects on the myocardium, and imaging features of cardiomyopathies induced by chemotherapy.


We will review pathophysiology of chemotherapy induced cardiomyopathy including:


- Dose dependent cardiomyopathy


- Predisposing conditions –diabetes, presence of coronary artery disease, age.


- Potential reversibility


We will discuss imaging characteristics of chemotherapy induced cardiomyopathy


- Imaging modalities ( Echocardiography, Cardiac MR, and MUGA)


- Importance of monitoring cardiac function during and after treatment


- Distribution of late Gadolinium enhancement (LGE)


- Emerging technologies for early diagnosis of cardiomyopathy in cancer patients


Conclusions:


Chemotherapy induced cardiomyopathy is a common problem among cancer patients, increasing long term morbidity and mortality and often leading to disability. Patients receiving chemotherapy treatment, particularly cardio toxic agents, should be routinely assessed for cardiac function to diagnose cardiomyopathy during the early phase of treatment and to prevent development of irreversible heart failure.


EXAMPLE POSTER SCIENTIFIC


The Value of 68Ga-PSMA Enhanced MR-PET in Patients with Biochemical Recurrent Prostate Cancer


Authors: E. Rummeny, K. Holzapel, T. Maurer, G. Weirich, E. Gschwend, M. Eiber


Aim:  In patients with prostate Cancer increased levels of PSMA can be measured. Recently a new tracer, 68Ga-PSMA, was developed as a specific marker for hybrid imaging (PET/CT, MR-PET). In this study we evaluated the accuracy of 68Ga-PSMA in patients with rising PSA after radical prosatectomy, so called „biochemical recurrent prostate cancer“ (BRPC).


Materials and Methods:  A total of 322 patients with BRPC underwent a MR-PET examination (Siemens Biograph mMR) after injection of about 150 mBq 68Ga-PSMA. Images were evaluated in cosensus by one experienced nuclear medicine physician  and one radiologist. Pelvine lymphnode dissection was performed in most of the patients according to a predefined template with 8 fields. Lymphnode involvement was evaluated according to a 5 point scale with a patient-  and a field-based analysis.  These findings were startified according to PSA-values.


Results:  Four patients were excluded from the study for different reasons. Sensitivity for detction of recurrence was 95.7 % for PSA-values ≥ 2ng/ml, 81.4 % for PSA-values of 1-2 ng/ml, 76% for PSA-values 0.5-1 ng/ml, and 51% for PSA values ≤ 0.5 ng/ml. In comparison to the MR-images alone MR-PET was of superior diagnostic value.


Conclusions:  MR-PET using 68Ga-PSMA is a sensitive and highly accurate technique for the diagnosis of  biochemical reccurence of prostate cancer after radical prostatectomy. It yields high diagnostic performance at relatively low PCA-values.

Sponsors Exhibitors
General Info

ICIS wish to thank the following companies supporting the International Cancer Imaging Society Meeting and 17th Annual Teaching Course: 


Guerbet (Society Corporate Supporter ), Bracco, Beckelmann, Medtron, Medtronic, Sirtex, Mint Medical, Siemens, Mevis, Roche

Contact
Organising Agency

Contact No.: +49 30 28879834

Email: admin@cancerimagingsociety.org.uk

Event map
Revelant Events